Relationship Between Shear Wave Elastography Findings and Histologic Prognostic Factors of Invasive Breast Cancer.
Journal
Ultrasound quarterly
ISSN: 1536-0253
Titre abrégé: Ultrasound Q
Pays: United States
ID NLM: 8809459
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
14
9
2019
medline:
15
12
2020
entrez:
14
9
2019
Statut:
ppublish
Résumé
Shear wave elastography (SWE) is an adjunct to grayscale ultrasound examinations for evaluating breast masses. This study aimed to determine the SWE features that correlated with prognostic parameters for breast cancer. Between January 2018 and May 2018, 80 patients who were confirmed to have invasive cancers by core-needle biopsy and who were scheduled for surgery were imaged using B-mode ultrasound and SWE. Measurements were taken from a region of interest positioned over the stiffest part of the peripheral zone and mass. Three measurements were taken, and the average of the mean stiffness value was used for analysis. The mean tumor size, elasticity value of tumors, and elasticity of the peripheral zone were 2.9 ± 1.48 cm (range, 0.6-8 cm), 154.8 ± 8.55 kPa (range, 116.25-179 kPa), and 171.34 ± 5.22 kPa (range, 150.95-182.43 kPa), respectively. The types of breast cancer included were invasive ductal carcinoma (n = 71 [88.75%]; 69 invasive ductal carcinoma not otherwise specified, 1 solid papillary carcinoma, and 1 invasive micropapillary carcinoma), invasive lobular carcinoma (n = 2 [2.5%]), mixed invasive ductal and lobular carcinoma (n = 4 [5%]), mucinous carcinoma (n = 2 [2.5%]), and metaplastic cancer (n = 1 [1.25%]). A strong correlation was found between mean elasticity values and tumor grade (P = 0.018) and between mean elasticity values and lymphovascular invasion (LVI) positivity (P = 0.008). There were no significant differences between SWE values and tumor diameter or between histological tumor characteristics and SWE. We found that some clinicohistopathologic features of poor prognosis had higher elasticity values than those of favorable prognosis.
Identifiants
pubmed: 31517740
doi: 10.1097/RUQ.0000000000000471
pii: 00013644-202003000-00015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-83Références
Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–187.
de Ronde JJ, Hannemann J, Halfwerk H, et al. Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response. Breast Cancer Res Treat. 2010;119:119–126.
Denley H, Pinder SE, Elston CW, et al. Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol. 2001;54:20–24.
Tang P, Skinner KA, Hicks DG. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol. 2009;18:125–132.
Park S, Koo JS, Kim MS, et al. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Breast. 2012;21:50–57.
Onitilo AA, Engel JM, Greenlee RT, et al. Breast cancer subtypes based on ER/PR and HER2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009;7:4–13.
Ko KH, Jung HK, Kim SJ, et al. Potential role of shear-wave ultrasound elastography for the differential diagnosis of breast non-mass lesions: preliminary report. Eur Radiol. 2014;24:305–311.
Lee EJ, Jung HK, Ko KH, et al. Diagnostic performances of shear wave elastography: which parameter to use in differential diagnosis of solid breast masses? Eur Radiol. 2013;23:1803–1811.
Barr RG. Real-time ultrasound elasticity of the breast. Ultrasound Q. 2010;26:61–66.
Au FW, Ghai S, Lu FI, et al. Quantitative shear wave elastography: correlation with prognostic histologic features and immunohistochemical biomarkers of breast cancer. Acad Radiol. 2015;22:269–277.
Gweon HM, Youk JH, Son EJ, et al. Clinical application of qualitative assessment for breast masses in shear-wave elastography. Eur J Radiol. 2013;82:e680–e685.
Au FW, Ghai S, Moshonov H, et al. Diagnostic performance of quantitative shear wave elastography in the evaluation of solid breast masses: determination of the most discriminatory parameter. AJR Am J Roentgenol. 2014;203:W328–W336.
Barr RG, Nakashima K, Amy D, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 2: breast. Ultrasound Med Biol. 2015;41:1148–1160.
Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155–168.
Moeder CB, Giltnane JM, Harigopal M, et al. Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome. J Clin Oncol. 2007;25:5418–5425.
Evans A, Whelehan P, Thomson K, et al. Quantitative shear wave ultrasound elastography: initial experience in solid breast masses. Breast Cancer Res. 2010;12:R104.
Evans A, Whelehan P, Thomson K, et al. Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 2012;263:673–677.
Chang JM, Moon WK, Cho N, et al. Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases. Breast Cancer Res Treat. 2011;129:89–97.
Youk JH, Gweon HM, Son EJ, et al. Diagnostic value of commercially available shear-wave elastography for breast cancers: integration into BI-RADS classification with subcategories of category 4. Eur Radiol. 2013;23:2695–2704.
Walker RA. The complexities of breast cancer desmoplasia. Breast Cancer Res. 2001;3:143–145.
Evans A, Rauchhaus P, Whelehan P, et al. Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer? Breast Cancer Res Treat. 2014;143:153–157.
Ganau S, Andreu FJ, Escribano F, et al. Shear-wave elastography and immunohistochemical profiles in invasive breast cancer: evaluation of maximum and mean elasticity values. Eur J Radiol. 2015;84:617–622.
Kang HJ, Kim JY, Lee NK, et al. Three-dimensional versus two-dimensional shear-wave elastography: associations of mean elasticity values with prognostic factors and tumor subtypes of breast cancer. Clin Imaging. 2018;48:79–85.
Song EJ, Sohn YM, Seo M. Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer. Br J Radiol. 2018;91:20170830.
Ren WW, Li XL, He YP, et al. Two-dimensional shear wave elastography of breast lesions: comparison of two different systems. Clin Hemorheol Microcirc. 2017;66:37–46.
Vinnicombe SJ, Whelehan P, Thomson K, et al. What are the characteristics of breast cancers misclassified as benign by quantitative ultrasound shear wave elastography? Eur Radiol. 2014;24:921–926.
Sim YT, Vinnicombe S, Whelehan P, et al. Value of shear-wave elastography in the diagnosis of symptomatic invasive lobular breast cancer. Clin Radiol. 2015;70:604–609.
Evans A, Sim YT, Thomson K, et al. Shear wave elastography of breast cancer: sensitivity according to histological type in a large cohort. Breast. 2016;26:115–118.
Berg WA, Cosgrove DA, Doré CJ, et al. Shear-wave elastography improves the specificity of breast US: the BE1 multi-national study of 939 masses. Radiology. 2012;262:435–449.